Clinical Trials

Find a Trial

Trial Summary

Protocol No.PHO-COG-FALLON-AOST1321
StatusOPEN TO ACCRUAL
Principal InvestigatorPradhan, Kamnesh
ScopeNational
PhasePhase II
Age GroupChildren
TitlePhase 2 Study of Denosumab (IND# 127430, NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma
Description
Key Eligibility
Applicable Disease SitesBone Cancer
Participating InstitutionsIndiana University (IU)
  • Riley Hospital for Children
Treatment TypeTreatment
ContactMelissa Lee, Phone: 317-944-4281
Pager: 312-1228
Email: mellee@iu.edu